Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy. [PDF]
Zhang X, Zhao Q, Li B.
europepmc +1 more source
Thyrotropin and IgG from patients with Graves' disease induce class-II antigen on human thyroid cells [PDF]
Drexhage, H. A. +5 more
core
Effects of high-dose glucocorticoids on gut microbiota in the treatment of Graves' ophthalmopathy. [PDF]
Su X, Tian Z, Fang Y, Zhou S, Ma S.
europepmc +1 more source
Inflammatory Proteins Mediate the Effect of Gut Microbiota on Graves' Ophthalmopathy: A Mendelian Randomization Study. [PDF]
Li Y +6 more
europepmc +1 more source
Psychological aspects of Graves' ophthalmopathy. [PDF]
Al-Badri WKW +5 more
europepmc +1 more source
Simvastatin-Induced Ferroptosis in Orbital Fibroblasts in Graves' Ophthalmopathy. [PDF]
Wang L +10 more
europepmc +1 more source
Combining biomarkers to predict the disease activity of graves' ophthalmopathy: a combinatory model of the NLR, TRAb and FT4. [PDF]
Niu T +8 more
europepmc +1 more source
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface [PDF]
core +1 more source

